Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.360
+0.170 (5.33%)
At close: Apr 24, 2025, 4:00 PM
3.350
-0.010 (-0.30%)
Pre-market: Apr 25, 2025, 5:05 AM EDT
IOVA's stock price has decreased by -71.67% in the past year and price targets may not have had time to catch up.
Iovance Biotherapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$18.22
Upside
+442.26%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +376.19% | Apr 17, 2025 |
| Barclays | Barclays | Buy Maintains $22 → $5 | Buy | Maintains | $22 → $5 | +48.81% | Apr 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $15 | Strong Buy | Maintains | $25 → $15 | +346.43% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +465.48% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $34 → $30 | Strong Buy | Maintains | $34 → $30 | +792.86% | Mar 3, 2025 |
| Baird | Baird | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +495.24% | Feb 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $7.5 → $6 | Hold | Maintains | $7.5 → $6 | +78.57% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +852.38% | Feb 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $10 → $7.5 | Hold | Maintains | $10 → $7.5 | +123.21% | Jan 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +852.38% | Nov 6, 2024 |
| UBS | UBS | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +405.95% | Oct 24, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +852.38% | Aug 12, 2024 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $19 → $10 | Buy → Hold | Downgrades | $19 → $10 | +197.62% | Jul 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +852.38% | Jun 28, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $25 → $23 | Buy | Maintains | $25 → $23 | +584.52% | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +852.38% | Jun 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.